Journal article
A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma
Abstract
BACKGROUND: Guidelines recommend reducing treatment in patients with well-controlled asthma after 3 months of stability. However, there is inadequate real-life data to guide physicians on therapy change in daily practice.
OBJECTIVE: To assess asthma control after change to and step-down of fluticasone propionate/formoterol fumarate dihydrate (FP/FOR) in real-life patients.
Authors
Usmani OS; Kemppinen A; Gardener E; Thomas V; Konduru PR; Callan C; McLoughlin A; Woodhead V; Brady A; Juniper EF
Journal
The Journal of Allergy and Clinical Immunology In Practice, Vol. 5, No. 5, pp. 1378–1387.e5
Publisher
Elsevier
Publication Date
September 2017
DOI
10.1016/j.jaip.2017.02.006
ISSN
2213-2198